COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 2 of 2 for:    LFB USA

A Phase III Study on the Safety, Pharmacokinetics and Efficacy of Coagulation Factor VIIa (PERSEPT2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02448680
Recruitment Status : Unknown
Verified January 2017 by LFB USA, Inc..
Recruitment status was:  Recruiting
First Posted : May 19, 2015
Last Update Posted : January 25, 2017
Laboratoire français de Fractionnement et de Biotechnologies
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : June 30, 2017
Estimated Study Completion Date : August 30, 2017